See if you may qualify for Relmada’s depression study

The Relight clinical research program is testing an investigational medication for people living with Major Depressive Disorder (MDD).

If you are interested in learning more about the study, or our investigational drug REL-1017, please send an email to clinicaltrials@relmada.com.

If you are interested in participating in the study please complete the prescreening questionnaire to see if you may qualify.